Peter C Richardson
CIK 1343502 · EVP & Chief Scientific Officer · last filed 2025-08-04
Peter C Richardson is an EVP & Chief Scientific Officer who has filed 27 SEC Form 4 insider transactions across 3 companies since 2007. Across all open-market trades the lifetime net is −$237.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $489.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$489.0K
3
27
-$237.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Keenova Therapeutics plc (MNK) Delisted | EVP & Chief Scientific Officer | 75,091 | $0.34 | $25.5K | $0 | 3 | 2023-07-05 |
| ANTARES PHARMA, INC. (ATRS) Delisted | EVP, R&D Chief Medical Officer | 36,199 | $5.59 | $202.4K | $0 | 2 | 2021-06-14 |
| MNKD | Chief Scientific Officer | 133,611 | $3.66 | $489.0K | -$237.6K | 17 | 2012-03-06 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-04 | — | Grant (A) | — | $0 | |
| 2025-01-02 | — | Exer (M) | +3,419 | $0 | |
| 2024-02-06 | — | Grant (A) | — | $0 | |
| 2023-11-16 | — | Disp (D) | −75,091 | $0 | |
| 2023-07-05 | Keenova Therapeutics plc (MNK) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-04-05 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-03 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +75,091 | $0 | EDGAR |
| 2022-05-26 | — | Disp (D) | −50,613 | -$283.4K | |
| 2021-06-14 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | +36,199 | $160.0K | EDGAR |
| 2021-04-28 | ANTARES PHARMA, INC. (ATRS) Delisted | Grant (A) | — | $0 | EDGAR |